Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT04515459
Recruiting
Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma
Phase 2 · France · 1 site
Registry update: 15 Sept 2025
NCT05227326
Recruiting
AOH1996 for the Treatment of Refractory Solid Tumors
Phase 1 · United States · 3 sites
Registry update: 20 Oct 2026
NCT05333458
Recruiting
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
Phase 2 · United States · 13 sites
Registry update: 5 Nov 2026
NCT05774275
Recruiting
The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma
Phase 1/2 · China · 1 site
Registry update: 26 May 2026
NCT05304585
Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Phase 3 · Australia, Canada, New Zealand, United States · 181 sites
Registry update: 25 Aug 2026
NCT05839275
Recruiting
The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma
Phase 1/2 · China · 1 site
Registry update: 21 Aug 2023
NCT05135975
Recruiting
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Phase 2 · United States · 6 sites
Registry update: 12 Aug 2025
NCT05761054
Recruiting
Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT)
Not applicable · Italy · 1 site
Registry update: 9 Mar 2023
NCT04897321
Recruiting
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1 · United States · 1 site
Registry update: 19 May 2026
NCT05297734
Recruiting
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Not applicable · United States · 17 sites
Registry update: 30 Apr 2026
2022-501180-40-00
Recruiting
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
Phase 3 · Austria, Belgium, Germany, Finland, Greece, Hungary, Poland, Sweden · 102 sites
Registry update: 19 Oct 2026
NCT06017518
Recruiting
An Observational Study of Local Relapse After High Grade Osteosarcoma
Not applicable · Italy · 2 sites
Registry update: 22 Sept 2025
NCT05245500
Recruiting
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Phase 1 · United States · 24 sites
Registry update: 2 Sept 2026
NCT05526417
Recruiting
Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma
Not applicable · United States · 1 site
Registry update: 22 Jun 2026
NCT05301283
Recruiting
Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma
Phase 2 · United States · 1 site
Registry update: 4 Dec 2025
NCT05366881
Recruiting
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Not applicable · United States · 17 sites
Registry update: 4 Nov 2026
NCT05182164
Recruiting
Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
Phase 2 · France · 10 sites
Registry update: 7 Oct 2025
NCT06482957
Recruiting
Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
Not applicable · United States · 1 site
Registry update: 19 Sept 2025
NCT05235165
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 · Australia, Canada, New Zealand, Puerto Rico, Saudi Arabia, United States · 233 sites
Registry update: 25 Aug 2026
NCT05296564
Recruiting
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Phase 1/2 · Israel · 1 site
Registry update: 2 Oct 2025

Ordered by registry start date. Freshness and sponsorship never change the order.